Drug Profile
UC 38
Alternative Names: NSC 629243Latest Information Update: 11 Sep 1996
Price :
$50
*
At a glance
- Originator Uniroyal Chemical
- Developer National Cancer Institute (USA)
- Class Antiretrovirals; Benzoic acids
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 11 Sep 1996 Discontinued-Preclinical for HIV-1 infections in USA (PO)
- 01 Mar 1996 A preclinical study has been added to the pharmacokinetics section
- 02 May 1995 New profile